A gastroenterologist with a strong background in research and development, Tadataka (Tachi) Yamada, M.D., accepted the role of chief medical and scientific officer for Takeda Pharmaceuticals in 2011. In addition to creating an organizational structure that resulted in improved productivity and a stronger line of products, Dr. Tachi Yamada shares his talents as a member of the Tokyo-based company’s board of directors.
Early in his career, Dr. Tadataka Yamada spent almost 13 years at the University of Michigan Medical School in Ann Arbor as head of the division of gastroenterology and later as chair of the department of internal medicine. His job included oversight of the teaching, research, and clinical practice of some 500 members of the faculty. Under his leadership, the department became known as one of the best in the world. For his efforts, he was recognized with membership to the Institute of Medicine of the National Academy of Science. Additionally, he served as president of the Association of American Physicians and the American Gastroenterology Association.
After leaving the university, Dr. Tachi Yamada spent a decade chairing the research and development division of GlaxoSmithKline in London and later worked with the Bill & Melinda Gates Foundation as president of the foundation’s Global Health Program.
In addition to serving as a member of Takeda Pharmaceuticals board, Dr. Tadataka Yamada also sits on several boards for high-profile organizations in the United States and abroad. They include the Clinton Health Access Initiative (CHAI) Foundation, which helps to ensure millions of people have access to affordable, quality HIV and AIDS treatments.